Meanwhile, it significantly reduced Treg cells CD4+CD25+Foxp3+ in the tumor microenvironment in comparison to PBS group (6.13%, 2.32%, 5%, and 12.9%) respectively (Fig. 3A,B). Here, FOXP3 is linked to neoplasm.